Carl Eriksson - Dissemin

Language
Login

All papers authored by Carl Eriksson

This paper is made freely available by the publisher.

2021 Isabella Visuri, Carl Eriksson

ORCID

, Ola Olén, Yang Cao, Emelie Mårdberg, Olof Grip, Anders Gustavsson, Henrik Hjortswang, Pontus Karling, Scott Montgomery, Pär Myrelid, Jonas F. Ludvigsson, Jonas Halfvarson

Predictors of drug survival: A cohort study comparing anti‐tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

Frank Phillips

ORCID

, Bram Verstockt

ORCID

, Malgorzata Sladek, Nanne de Boer, Konstantinos Katsanos, Konstantinos Karmiris, Ahmad Albshesh

ORCID

, Carl Erikson

ORCID

, Daniel Bergemalm, Tamas Molnar, Pierre Ellul

Orofacial Granulomatosis Associated with Crohn’s Disease: a Multicentre Case Series

Download from academic.oup.com

This paper was not found in any repository, but could be made available legally by the author.

Isabella Visuri

ORCID

, Carl Eriksson

ORCID

, Ola Olén, Yang Cao, Emelie Mårdberg, Olof Grip, Anders Gustavsson, Henrik Hjortswang, Pontus Karling, Scott Montgomery, Pär Myrelid

ORCID

, Jonas F. Ludvigsson

ORCID

, Jonas Halfvarson

Editorial: infliximab or adalimumab as first‐ or second‐line anti‐TNF—conflicting evidence—authors' reply

Upload

Distributing this paper is prohibited by the publisher

Carl Eriksson

ORCID

, Isabella Visuri, Lina Vigren, Linda Nilsson, Anders Kärnell, Henrik Hjortswang, Daniel Bergemalm, Sven Almer, Erik Hertervig, Per Karlén, Hans Strid, Jonas Halfvarson

Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG

Upload

This paper is made freely available by the publisher.

Ahmad Albshesh

ORCID

, Joshua Taylor, Edoardo V. Savarino, Marie Truyens, Alessandro Armuzzi, Davide G. Ribaldone

ORCID

, Ariella Bar-Gil Shitrit, Morine Fibelman, Pauliina Molander, Claire Liefferinckx, Stephane Nancey, Mohamed Korani, Mariann Rutka, Manuel Barreiro-De Acosta

ORCID

, Viktor Domislovic and 31 other authors

Effectiveness of Third-Class Biologic Treatment in Crohn’s Disease: A Multi-Center Retrospective Cohort Study

Download from doi.org

This paper is made freely available by the publisher.

Carl Eriksson

ORCID

, Sara Rundquist, Vyron Lykiardopoulos, Ruzan Udumyan, Per Karlén, Olof Grip, Charlotte Söderman, Sven Almer, Erik Hertervig, Jan Marsal, Jenny Gunnarsson, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjöberg and 4 other authors

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

Download from journals.sagepub.com

Distributing this paper is prohibited by the publisher

2020 Sarita Shrestha, Ola Olén, Carl Eriksson

ORCID

, Åsa H. Everhov, Pär Myrelid, Isabella Visuri, Jonas F. Ludvigsson, Ida Schoultz, Scott Montgomery, Michael C. Sachs, Jonas Halfvarson, Malin Olsson, Henrik Hjortswang, Jonas Bengtsson, Hans Strid and 13 other authors

The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register

Upload

This paper was not found in any repository, but could be made available legally by the author.

2019 Annick Moens

ORCID

, C. Janneke van der Woude, Mette Julsgaard

ORCID

, Evelien Humblet, Juliette Sheridan, Daniel C. Baumgart, Cyrielle Gilletta De Saint-Joseph, Stéphane Nancey, Jean-François Rahier, Peter Bossuyt, Anneline Cremer, Sophie Dewit, Carl Eriksson

ORCID

, Frank Hoentjen, Thomas Krause and 10 other authors

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study

Upload

This paper was not found in any repository, but could be made available legally by the author.

Johan Burisch, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Luisa Barros, Fernando Magro, Natalia Pedersen, Jens Kjeldsen, Zsuzsanna Vegh, Peter L. Lakatos, Carl Eriksson

ORCID

, Jonas Halfvarson, Mathurin Fumery, Corinne Gower-Rousseau, Marko Brinar, Silvija Čuković-Čavka and 33 other authors

Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort—An Epi-IBD Study

Upload

This paper was not found in any repository, but could be made available legally by the author.

2018 Sara Rundquist

ORCID

, Carl Eriksson

ORCID

, Linda Nilsson, Leif Angelison, Susanna Jäghult, Jan Björk, Olof Grip, Henrik Hjortswang, Hans Strid, Per Karlén, Scott Montgomery, Jonas Halfvarson

Clinical effectiveness of golimumab in Crohn’s disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)

Upload

This paper is made freely available by the publisher.

Carl Eriksson

ORCID

, Ida Henriksson, Ole Brus, Yaroslava Zhulina, Nils Nyhlin, Curt Tysk, Scott Montgomery, Jonas Halfvarson

ORCID

Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population-based cohort study

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Carl Eriksson

ORCID

, Sara Rundquist, Yang Cao, Scott Montgomery, Jonas Halfvarson

Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study

Upload

This paper was not found in any repository, but could be made available legally by the author.

Johan Burisch

ORCID

, Gediminas Kiudelis, Limas Kupcinskas, Hendrika Adriana Linda Kievit, Karina Winther Andersen, Vibeke Andersen

ORCID

, Riina Salupere, Natalia Pedersen, Jens Kjeldsen, Renata D’Incà, Daniela Valpiani, Doron Schwartz, Selwyn Odes, Jóngerð Olsen, Kári Rubek Nielsen and 31 other authors

Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study

Upload

This paper is made freely available by the publisher.

2017 C. Eriksson

ORCID

, Y. Cao, S. Rundquist, Y. Zhulina, I. Henriksson, S. Montgomery, J. Halfvarson

ORCID

Editorial: do thiopurines and biologics decrease the risk of colectomy? Authors’ reply

Download from onlinelibrary.wiley.com

Distributing this paper is prohibited by the publisher

Jan Marsal, Lina Vigren, Pontus Karling, Charlotte Söderman, Pär Myrelid, Daniel Sjöberg, Mari Thörn, Per Karlén, Erik Hertervig, Hans Strid, Jonas F. Ludvigsson, Jonas Halfvarson, Daniel Bergemalm, Jan Björk, Michael Eberhardson and 3 other authors

Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).

Upload

This paper is available in a repository.

2011 Anders Gustavsson, Thomas Kronvall, Curt Tysk, Carl Eriksson

ORCID

Hepatotoxicity by Bosentan in a Patient with Portopulmonary Hypertension: a Case-Report and Review of the Literature

Download from www.researchgate.net

Missing publications? Search for publications with a matching author name.